Trial intelligence / Profile preview

PLANET: Zibotentan + Carboplatin in Metastatic Breast Cancer

NCT01134497Phase 2Withdrawn

Sponsor
Cardiff University
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zibotentan in breast cancer, sponsored by Cardiff University. Status: withdrawn.

02

Drugs

zibotentan
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01134497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01134497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call